Suppr超能文献

低氧诱导因子脯氨酰羟化酶抑制可保护骨骼肌免受离心收缩损伤。

HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury.

机构信息

Muscle Metabolism Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA.

Target Sciences, GlaxoSmithKline, King of Prussia, PA, USA.

出版信息

Skelet Muscle. 2018 Nov 13;8(1):35. doi: 10.1186/s13395-018-0179-5.

Abstract

BACKGROUND

In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcription under conditions of low oxygen, and HIF target genes EPO and VEGF have been associated with muscle protection and repair. We tested the importance of HIF activation following skeletal muscle injury, in both a murine model and human volunteers, using prolyl hydroxylase inhibitors that stabilize and activate HIF.

METHODS

Using a mouse eccentric limb injury model, we characterized the protective effects of prolyl hydroxylase inhibitor, GSK1120360A. We then extended these studies to examine the impact of EPO modulation and infiltrating immune cell populations on muscle protection. Finally, we extended this study with an experimental medicine approach using eccentric arm exercise in untrained volunteers to measure the muscle-protective effects of a clinical prolyl hydroxylase inhibitor, daprodustat.

RESULTS

GSK1120360A dramatically prevented functional deficits and histological damage, while accelerating recovery after eccentric limb injury in mice. Surprisingly, this effect was independent of EPO, but required myeloid HIF1α-mediated iNOS activity. Treatment of healthy human volunteers with high-dose daprodustat reduced accumulation of circulating damage markers following eccentric arm exercise, although we did not observe any diminution of functional deficits with compound treatment.

CONCLUSION

The results of these experiments highlight a novel skeletal muscle protective effect of prolyl hydroxylase inhibition via HIF-mediated expression of iNOS in macrophages. Partial recapitulation of these findings in healthy volunteers suggests elements of consistent pharmacology compared to responses in mice although there are clear differences between these two systems.

摘要

背景

在肌肉萎缩症和老年人群中,骨骼肌的修复受到损害,导致纤维化和脂肪组织积累。因此,保护骨骼肌或增强修复的疗法将是有价值的医学治疗方法。缺氧诱导因子(HIFs)在低氧条件下调节基因转录,HIF 的靶基因 EPO 和 VEGF 与肌肉保护和修复有关。我们使用脯氨酰羟化酶抑制剂(可稳定和激活 HIF)在鼠模型和人类志愿者中测试了骨骼肌损伤后 HIF 激活的重要性。

方法

我们使用小鼠离心肢体损伤模型,研究了脯氨酰羟化酶抑制剂 GSK1120360A 的保护作用。然后,我们将这些研究扩展到研究 EPO 调节和浸润免疫细胞群对肌肉保护的影响。最后,我们使用未受过训练的志愿者进行离心手臂运动的实验医学方法,扩展了这项研究,以测量临床脯氨酰羟化酶抑制剂 daprodustat 的肌肉保护作用。

结果

GSK1120360A 可显著预防功能缺陷和组织学损伤,并加速小鼠离心肢体损伤后的恢复。令人惊讶的是,这种作用独立于 EPO,但需要髓样 HIF1α 介导的 iNOS 活性。用高剂量 daprodustat 治疗健康的人类志愿者可减少离心手臂运动后循环损伤标志物的积累,尽管我们在联合治疗中没有观察到任何功能缺陷的减少。

结论

这些实验的结果突出了脯氨酰羟化酶抑制通过巨噬细胞中 HIF 介导的 iNOS 表达对骨骼肌的保护作用。在健康志愿者中部分再现这些发现表明与小鼠的反应相比,化合物治疗具有一致的药理学特征,尽管这两个系统之间存在明显差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d97/6234580/a1ee35107ecd/13395_2018_179_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验